In this case, IL-2 was labelled with fluorine-18 via reaction with succinimidyl 4-[18F]-fluorobenzoate ([18F]SFB) to monitor tumorreactive T cells directly at the tumor site [86]. The gene discussed is IL2; the disease is neoplasm.